Erschienen in:
28.02.2018 | Correspondence
Reply to letter by Dr. G. Corso
verfasst von:
Frederik Stuebs, Simone Heidemann, Almuth Caliebe, Christoph Mundhenke, Norbert Arnold
Erschienen in:
Archives of Gynecology and Obstetrics
|
Ausgabe 4/2018
Einloggen, um Zugang zu erhalten
Excerpt
We would like to thank Giovanni Corso et al. for their “Letter to the editor”. In our study, we screened 97 individuals for
CDH1 mutations. Screening revealed two missense variants in independent families. The first alteration, A592T, was classified as neutral. The other variant, S838G, was detected in an unaffected woman with a family history of
BRCA1-positive breast- and ovarian cancer without gastric cancer. Our index case was tested negative for the familial
BRCA1 mutation. In the past, the variant S838G has been classified as potentially deleterious [
1]. Searching the Alamut-Database (Alamut Visual 2.10) revealed contradictory rating of the variant from likely benign to pathogenic, whereas the pathogenic classification probably also was judged by the paper of Risinger et al. [
1]. In addition, in dbSNP, one will find this spectrum of rating (rs121964872). A request to Ambry Genetics for the reason why they judge the variant as likely benign revealed following answer: The serine at codon 838 is replaced by glycine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. This variant has been seen in several families whose clinical histories are not consistent with hereditary diffuse gastric cancer or other CDH1-related cancers (Ambry Internal data). In addition, this alteration is predicted to be benign and tolerated by PolyPhen and SIFT in silico analyses, respectively. Based on the majority of available evidence to date, this variant is unlikely to be pathogenic. Therefore, the cases of breast and ovarian cancer in the reported family are most likely caused by the
BRCA1 mutation. Unfortunately, we had no possibilities to test the segregation of this missense variant S838G in other family members. This is why, we cannot exclude that this
CDH1 variant could have a modifying influence on breast cancer causing the lobular histology. …